Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.75M | 3.93M | 3.91M | 3.96M | 3.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.33M | 6.97M | 6.92M | 6.98M | 6.72M |
| Operating Income | -7.33M | -6.97M | -6.92M | -6.98M | -6.72M |
| Income Before Tax | -7.27M | -6.90M | -6.85M | -6.85M | -6.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.27 | -6.90 | -6.85 | -6.85 | -6.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.27M | -6.90M | -6.85M | -6.85M | -6.74M |
| EBIT | -7.33M | -6.97M | -6.92M | -6.98M | -6.72M |
| EBITDA | -7.24M | -6.88M | -6.84M | -6.91M | -6.65M |
| EPS Basic | -8.68 | -13.21 | -24.72 | -34.03 | -337.75 |
| Normalized Basic EPS | -5.40 | -8.23 | -15.43 | -21.27 | -38.12 |
| EPS Diluted | -8.68 | -13.21 | -24.72 | -34.03 | -337.75 |
| Normalized Diluted EPS | -5.40 | -8.23 | -15.43 | -21.27 | -38.12 |
| Average Basic Shares Outstanding | 4.37M | 2.64M | 1.80M | 1.01M | 664.80K |
| Average Diluted Shares Outstanding | 4.37M | 2.64M | 1.80M | 1.01M | 664.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |